Pharmaceutical Companies

I-MAB Biopharma Co., Ltd.

Country: 🇨🇳China

Ownership: Public, Subsidiary

Established: 2016-08-24

Employees: 251

Market Cap: $101.9M

Website: http://www.i-mabbiopharma.com

I-MAB Biopharma Co., Ltd.

🇨🇳China

Ownership: Public, Subsidiary

Established: 2016-08-24

Employees: 251

Market Cap: $101.9M

Website: http://www.i-mabbiopharma.com

CASI PHARMACEUTICALS INC.

Country: 🇰🇾Cayman Islands

Ownership: Public

Established: -

Employees: 243

Market Cap: $100.6M

Website: http://www.casipharmaceuticals.com

CASI PHARMACEUTICALS INC.

🇰🇾Cayman Islands

Ownership: Public

Established: -

Employees: 243

Market Cap: $100.6M

Website: http://www.casipharmaceuticals.com

Karyopharm Therapeutics Inc

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $99.7M

Website: -

Karyopharm Therapeutics Inc

🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $99.7M

Website: -

Werewolf Therapeutics

Country: 🇺🇸United States

Ownership: Public

Established: 2017-01-01

Employees: 47

Market Cap: $99.6M

Website: http://www.werewolftx.com

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.

Werewolf Therapeutics

🇺🇸United States

Ownership: Public

Established: 2017-01-01

Employees: 47

Market Cap: $99.6M

Website: http://www.werewolftx.com

Verastem Oncology

Country: 🇺🇸United States

Ownership: -

Established: 2010-01-01

Employees: -

Market Cap: $99.4M

Website: https://www.verastem.com

Verastem Oncology

🇺🇸United States

Ownership: -

Established: 2010-01-01

Employees: -

Market Cap: $99.4M

Website: https://www.verastem.com

Sagimet Biosciences

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 10

Market Cap: $97.8M

Website: -

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and...

Sagimet Biosciences

🇺🇸United States

Ownership: -

Established: -

Employees: 10

Market Cap: $97.8M

Website: -

Oramed Pharmaceuticals

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 15

Market Cap: $97.4M

Website: -

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and...

Oramed Pharmaceuticals

🇺🇸United States

Ownership: -

Established: -

Employees: 15

Market Cap: $97.4M

Website: -

Intercure

Country: 🇺🇸United States

Ownership: -

Established: 1994-01-01

Employees: -

Market Cap: $97M

Website: https://www.intercure.co/

Intercure

🇺🇸United States

Ownership: -

Established: 1994-01-01

Employees: -

Market Cap: $97M

Website: https://www.intercure.co/

HilleVax

Country: 🇺🇸United States

Ownership: Public

Established: -

Employees: 90

Market Cap: $96M

Website: http://www.hillevax.com

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.